Dr. Brent Tierney, MD
Claim this profileNebraska Methodist Hospital
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
23 reported clinical trials
42 drugs studied
About Brent Tierney, MD
Education:
- Obtained an MD (Doctor of Medicine) from the University of Nebraska Medical Center in 2015.
- Completed a Residency in Internal Medicine at Nebraska Methodist Hospital in 2018.
Experience:
- Currently practices as an internal medicine physician at Nebraska Methodist Hospital.
Area of expertise
1Ovarian Cancer
Global LeaderBRCA1 positive
Stage IV
Stage III
2Fallopian Tube Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Brent Tierney, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Targeted Therapy + Atezolizumab
for Endometrial Cancer
This trial tests drugs that target cancer cells, sometimes combined with an immune-boosting drug called atezolizumab. It focuses on patients with endometrial cancer that has returned or is persistent. The drugs are chosen based on the genetic profile of the patient's tumor to improve effectiveness.
Recruiting1 award Phase 1 & 25 criteria
More about Brent Tierney, MD
Clinical Trial Related2 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Brent Tierney, MD has experience with
- Paclitaxel
- Carboplatin
- Bevacizumab
- Cisplatin
- Letrozole
- Atezolizumab
Breakdown of trials Brent Tierney, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Adenocarcinoma
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brent Tierney, MD specialize in?
Brent Tierney, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are Stage IV.
Is Brent Tierney, MD currently recruiting for clinical trials?
Yes, Brent Tierney, MD is currently recruiting for 7 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Brent Tierney, MD has studied deeply?
Yes, Brent Tierney, MD has studied treatments such as Paclitaxel, Carboplatin, Bevacizumab.
What is the best way to schedule an appointment with Brent Tierney, MD?
Apply for one of the trials that Brent Tierney, MD is conducting.
What is the office address of Brent Tierney, MD?
The office of Brent Tierney, MD is located at: Nebraska Methodist Hospital, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.